Ian is also Chairman of Bioventix Ltd, a diagnostics company, Chief Executive Officer of F2G Ltd, a UK-based antifungal drug discovery and development company. He is also a non-executive director of Clinigen Group plc, a specialty pharmaceuticals and services business, and also an operating partner at Advent Life Sciences.
Ian is Chair of the Corporate Responsibility Committee and a member of the Audit Committee, the Remuneration Committee and the Nomination Committee at Consort Medical plc.
Past roles and experience:
From 2004 to 2012 Ian was Chief Executive of Chroma Therapeutics Limited, a drug discovery and development company and from 2000 to 2004 Senior Vice President, Business Development at Celltech Group plc, then the UK's largest biotechnology company.
Ian has extensive experience in licensing, mergers and acquisitions and market development in the UK, Europe and the US.